May 18, 2017 12:09 pm UTC| Business
MALVERN, Pa., May 18, 2017 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced the presentation...
May 18, 2017 12:09 pm UTC| Business
MALVERN, Pa., May 18, 2017 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced the presentation...
May 18, 2017 12:09 pm UTC| Business
MALVERN, Pa., May 18, 2017 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced the presentation...
May 18, 2017 12:09 pm UTC| Business
MALVERN, Pa., May 18, 2017 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced the presentation...
May 18, 2017 12:09 pm UTC| Business
MALVERN, Pa., May 18, 2017 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced the presentation...
May 18, 2017 12:09 pm UTC| Business
MALVERN, Pa., May 18, 2017 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced the presentation...
May 18, 2017 12:09 pm UTC| Business
MALVERN, Pa., May 18, 2017 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced the presentation...